Roche’s Obesity Drug Shows Promise But Trails GLP-1 Giants Novo Nordisk, Eli Lilly – Roche Holding (OTC:RHHBY)
Genentech on Thursday shared topline results from the Phase 2 ZUPREME-1 trial evaluating petrelintide versus placebo in 493…
Browsing Tag